Search results for "Left Ventricular Mass"

showing 10 items of 35 documents

Left ventricular structure and function in hypertensives with chronic renal insufficiency.

2006

Left ventricular masshypertension chronic renal insufficiency
researchProduct

PP.04.22

2015

Left ventricular massmedicine.medical_specialtyEndocrinologyPhysiologybusiness.industryInternal medicineInternal MedicineCardiologymedicineCardiology and Cardiovascular Medicinemedicine.diseasebusinessObesityJournal of Hypertension
researchProduct

24-hour ambulatory pulse pressure and left ventricular mass in essential hypertension

2000

Left ventricular massmedicine.medical_specialtyMegalencephalic leukoencephalopathy with subcortical cystsbusiness.industryInternal medicineAmbulatoryInternal MedicineCardiologyMedicinebusinessEssential hypertensionmedicine.diseasePulse pressureAmerican Journal of Hypertension
researchProduct

Left Ventricular Remodelling Conditions Left Atrial Volume and Function In Hypertensive Patients? Evaluation in RT3D Echocardiography

2007

Left ventricular massmedicine.medical_specialtyPharmacotherapybusiness.industryInternal medicineInternal MedicineCardiologyMedicineRenal functionCardiology and Cardiovascular MedicinebusinessHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Heredity and obesity-associated hypertension:impact on hormonal characteristics and left ventricular mass.

1995

Left ventricular massmedicine.medical_specialtybusiness.industryInternal medicineHeredityInternal MedicinemedicineCardiologybusinessmedicine.diseasemedicine.disease_causeObesityHormoneAmerican Journal of Hypertension
researchProduct

Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance

2017

Background. Single-photon emission computed tomography has shown relevant limitations in the quantification of left ventricular (LV) mass. We sought to compare the estimates of LV mass on Cadmium-Zinc-Telluride (CZT) myocardial perfusion imaging (MPI) as compared to cardiac magnetic resonance (CMR). Methods and results. Twenty-five patients underwent MPI on a CZT camera and CMR on a 1.5 T scanner within 12 ± 3 weeks. LV mass was quantified on CZT images using two softwares: 4D-MSPECT (4DM) and Emory Cardiac Toolbox (ECTb). LV mass by CMR was quantified using MASS software (Medis, Leiden, The Netherlands). LV mass values obtained with 4DM and ECTb were highly reproducible [intraclass correla…

MaleIntraclass correlationHeart Ventricles030204 cardiovascular system & hematologyleft ventricular masscardiac magnetic resonance030218 nuclear medicine & medical imagingHeart NeoplasmsLeft ventricular mass03 medical and health sciencesMyocardial perfusion imagingchemistry.chemical_compound0302 clinical medicinePredictive Value of TestsNuclear Medicine and ImagingHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesAged 80 and overTomography Emission-Computed Single-Photonmedicine.diagnostic_testbusiness.industryLimits of agreementMyocardial Perfusion ImagingReproducibility of ResultsCadmium-Zinc-Telluride Æ cardiac magnetic resonance Æ SPECT Æ left ventricular massMiddle AgedMagnetic Resonance ImagingCadmium zinc tellurideZincchemistryCadmium-Zinc-Telluride; cardiac magnetic resonance; left ventricular mass; SPECT; Radiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular MedicineSPECTCadmium-Zinc-TellurideFemaleTelluriumRadiologyCardiology and Cardiovascular MedicineNuclear medicinebusinessCardiac magnetic resonanceEmission computed tomographyCadmiumJournal of Nuclear Cardiology
researchProduct

Valve prosthesis-patient mismatch: hemodynamic, echocardiographic and clinical consequences

2011

OBJECTIVES: The purpose is to evaluate in vivo at rest and under stress conditions hemodynamic performance of the small size St. Jude Medical Regent (SJMR) prosthetic valve in patients with a body surface area (BSA) of 1.8 ± 0.11 m(2) and to define the role of valve prosthesis- patient mismatch on left ventricular mass regression following aortic valve replacement. METHODS: We evaluated 25 cases (12 males and 13 females, mean age 65.2 ± 8 years) of aortic valve replacement (17 mm SJMR in three cases and 19 mm SJMR in 22 cases). All the patients underwent at rest Doppler echocardiography before and after surgery and both basal and dobutamine stress echocardiography (DSE) at follow-up. The me…

MaleTime FactorsBody Surface Areamedicine.medical_treatmentLeft ventricular maHemodynamicsDoppler echocardiographyVentricular Function LeftValve replacementAortic valve replacementDobutamineCardiac skeletonBody surface areaHeart Valve Prosthesis ImplantationEjection fractionmedicine.diagnostic_testVentricular RemodelingMiddle AgedEchocardiography DopplerTreatment OutcomeAortic ValveHeart Valve ProsthesisCardiologyFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicineEchocardiography StressPulmonary and Respiratory Medicinemedicine.medical_specialtyProsthesis DesignPreoperative carePredictive Value of TestsInternal medicineProsthesis-patient mismatch; Left ventricular mass; Effective orifice area; DobutaminemedicineHumansAgedRetrospective StudiesChi-Square Distributionbusiness.industryHemodynamicsProsthesis-patient mismatchStroke VolumeSettore MED/23 - Chirurgia CardiacaAortic Valve StenosisRecovery of Functionmedicine.diseaseEffective orifice areaSurgerybusiness
researchProduct

Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects

2007

BACKGROUND: Metabolic syndrome (MS) has been associated with an increased left ventricular (LV) mass in recent reports. Little is known about the association of MS with LV mass (LVM) in overweight and obese individuals. The aim of our study was to investigate the relation between MS and LVM in a population of overweight and obese hypertensive subjects. METHODS: 289 non-diabetic essential hypertensives with a body mass index >25 kg/m2, were enrolled. In all subjects routine blood chemistry, echocardiographic examination and 24-h ambulatory blood pressure monitoring were performed. RESULTS: In the group of overweight patients, participants with MS (n=58), when compared to those without it (n=…

Malemedicine.medical_specialtyAmbulatory blood pressurePopulationOverweightEssential hypertensionBody Mass IndexRisk FactorsInternal medicinemedicineHumansObesityeducationmetabolic syndrome left ventricular mass hypertensionMetabolic Syndromeeducation.field_of_studyChi-Square Distributionbusiness.industryBody WeightMiddle AgedOverweightmedicine.diseaseEchocardiography DopplerCross-Sectional StudiesEndocrinologyBlood pressureBlood chemistryHypertensionLinear ModelsCardiologyFemaleHypertrophy Left VentricularMetabolic syndromemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexInternational Journal of Cardiology
researchProduct

Impact of metabolic syndrome on left ventricular mass: Is the same in all ethnic groups and in men and women?

2007

[1] Mule G, Nardi E, Cottone S, et al. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects. Int J Cardiol 2007;121:267–75. [2] Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8. [3] IsomaaB,Almgren P, TuomiT, et al. Cardiovascularmorbidity andmortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9. [4] Reilly MP, Rader DJ. The metabolic syndrome:…

Malemedicine.medical_specialtyRaceEthnic groupSindrome metabolica Ipertrofia ventricolare sinistra Ipertensione essenziale.OverweightLeft ventricular hypertrophyEssential hypertensionLeft ventricular massLeft ventricular massRace (biology)Sex FactorsDiabetes mellitusInternal medicineHumansMedicineCardiac structureObesityInternational diabetes federationbusiness.industryRacial GroupsGenderOverweightmedicine.diseaseMetabolic syndromeHypertensionCardiologyFemaleHypertrophy Left Ventricularmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk

2015

OBJECTIVE This study was designed to evaluate the relationship among circulating adiponectin (ADPN), left ventricular mass (LVM) and cardiometabolic comorbidities in subjects at higher global cardiovascular risk (score of “ Cuore Project “) METHODS. 115 consecutive subjects were grouped according to normal or low ADPN levels. Left ventricular internal diameter (LVID/h), total LV mass (LVM), LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters, by pulsed-wave Doppler were calculated. RESULTS Low-ADPN subjects were characterized by a significant higher prevalence of some cardiometabolic comorbidities (obesity, visceral obesity, dia…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaCardiac VolumeHeart VentriclesCardiac VolumeLeft ventricular hypertrophyRisk AssessmentVentricular Function LeftLeft ventricular massRisk FactorsInternal medicinePrevalencemedicineHumansEchocardiography Doppler PulsedVentricular functionAdiponectinbusiness.industryStroke VolumeAdiponectinGlobal cardiovascular riskleft ventricular hypertrophyGeneral MedicineStroke volumeMiddle AgedPrognosismedicine.diseaseItalyCardiovascular DiseasesCardiologyFemaleAdiponectinCardiology and Cardiovascular MedicinebusinessBiomarkersActa Cardiologica
researchProduct